Ariad Pharmaceuticals Inc (ARIA) financial statements (2020 and earlier)

Company profile

Business Address 26 LANDSDOWNE ST
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 242353237164
Cash and cash equivalents 231353237119
Short-term investments 11  45
Receivables 16810
Inventory, net of allowances, customer advances and progress billings 1100
Inventory 1100
Prepaid expense and other current assets4
Other current assets 16246
Other undisclosed current assets    (0)
Total current assets: 275386245168
Noncurrent Assets
Inventory, Noncurrent 103 
Property, plant and equipment 2542031098
Intangible assets, net (including goodwill) 1111
Intangible assets, net (excluding goodwill) 1111
Restricted cash and investments 1111111
Other undisclosed noncurrent assets 4222
Total noncurrent assets: 27121812612
TOTAL ASSETS: 547604371180
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 64464134
Accounts payable 1711118
Accrued liabilities 22141714
Employee-related liabilities 25211312
Debt   42
Deferred compensation liability   34
Deferred revenue and credits 241720
Customer advances and deposits  17
Other liabilities 2418151
Other undisclosed current liabilities 20(8)88
Total current liabilities: 132907249
Noncurrent Liabilities
Long-term debt and lease obligation 20015759
Long-term debt, excluding current maturities 20015759
Liabilities, other than long-term debt 93921112
Deferred revenue and credits 777601
Accounts payable and accrued liabilities 55  
Deferred compensation liability, classified    2
Liability for uncertainty in income taxes   22
Other liabilities 111197
Other undisclosed noncurrent liabilities 224   
Total noncurrent liabilities: 5182481621
Total liabilities: 6503388870
Stockholders' equity
Stockholders' equity attributable to parent (103)81186113
Common stock 0000
Additional paid in capital 1,3391,2991,239890
Accumulated other comprehensive income (loss) 4(4)(2)0
Accumulated deficit (1,446)(1,215)(1,052)(778)
Total stockholders' equity: (103)81186113
Other undisclosed liabilities and equity  18597(2)
TOTAL LIABILITIES AND EQUITY: 547604371180

Income statement (P&L) ($ in millions)

9/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues 119105461
Revenue, net 1135645 
Cost of revenue
(Cost of Goods and Services Sold)
 (2)(5)(17)(0)
Gross profit: 117100280
Operating expenses (336)(266)(319)(206)
Other undisclosed operating income 25170
Operating loss: (217)(160)(274)(205)
Nonoperating expense (17)(2)(0)(16)
Investment income, nonoperating 000(16)
Foreign currency transaction gain (loss), before tax 11(0)0
Interest and debt expense (18)(8)(0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes 1880 
Loss from continuing operations before income taxes: (235)(162)(274)(221)
Income tax expense (benefit) 3(1)(0) 
Net loss: (231)(163)(274)(221)
Other undisclosed net income attributable to parent    0
Net loss available to common stockholders, diluted: (231)(163)(274)(221)

Comprehensive Income ($ in millions)

9/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss: (231)(163)(274)(221)
Other comprehensive income (loss) 8(3)(2)0
Comprehensive loss: (223)(165)(276)(221)
Other undisclosed comprehensive income, net of tax, attributable to parent    0
Comprehensive loss, net of tax, attributable to parent: (223)(165)(276)(221)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: